Clinical Trial Update: Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluated a vaccine therapy for malignant peripheral nerve sheath tumors that are metastatic, recurrent, or unresectable in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor
• Neurofibromatosis Type

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 | Phase 1 | Status: COMPLETED